These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 2479838)
1. Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes. Bodmer H; Ogg G; Gotch F; McMichael A Nature; 1989 Nov; 342(6248):443-6. PubMed ID: 2479838 [TBL] [Abstract][Full Text] [Related]
2. Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein. Engelhard VH; Lacy E; Ridge JP J Immunol; 1991 Feb; 146(4):1226-32. PubMed ID: 1704033 [TBL] [Abstract][Full Text] [Related]
3. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes. Nijman HW; Houbiers JG; Vierboom MP; van der Burg SH; Drijfhout JW; D'Amaro J; Kenemans P; Melief CJ; Kast WM Eur J Immunol; 1993 Jun; 23(6):1215-9. PubMed ID: 7684681 [TBL] [Abstract][Full Text] [Related]
4. 707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma. Takahashi T; Irie RF; Nishinaka Y; Hoon DS Clin Cancer Res; 1997 Aug; 3(8):1363-70. PubMed ID: 9815820 [TBL] [Abstract][Full Text] [Related]
5. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Gotch F; Rothbard J; Howland K; Townsend A; McMichael A Nature; 1987 Apr 30-May 6; 326(6116):881-2. PubMed ID: 2437457 [TBL] [Abstract][Full Text] [Related]
7. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes. Morrison J; Elvin J; Latron F; Gotch F; Moots R; Strominger JL; McMichael A Eur J Immunol; 1992 Apr; 22(4):903-7. PubMed ID: 1372560 [TBL] [Abstract][Full Text] [Related]
8. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73. Shimojo N; Cowan EP; Engelhard VH; Maloy WL; Coligan JE; Biddison WE J Immunol; 1989 Jul; 143(2):558-64. PubMed ID: 2472444 [TBL] [Abstract][Full Text] [Related]
9. Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes. Ogg GS; Dunbar PR; Cerundolo V; McMichael AJ; Lemoine NR; Savage P Br J Cancer; 2000 Mar; 82(5):1058-62. PubMed ID: 10737389 [TBL] [Abstract][Full Text] [Related]
10. Specificity of peptide binding by the HLA-A2.1 molecule. Shimojo N; Maloy WL; Anderson RW; Biddison WE; Coligan JE J Immunol; 1989 Nov; 143(9):2939-47. PubMed ID: 2553813 [TBL] [Abstract][Full Text] [Related]
11. Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition. Matsui M; Moots RJ; Warburton RJ; Peace-Brewer AL; Tussey LG; Quinn DG; McMichael AJ; Frelinger JA J Immunol; 1995 Feb; 154(3):1088-96. PubMed ID: 7822785 [TBL] [Abstract][Full Text] [Related]
12. Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2. Robbins PA; Lettice LA; Rota P; Santos-Aguado J; Rothbard J; McMichael AJ; Strominger JL J Immunol; 1989 Dec; 143(12):4098-103. PubMed ID: 2480387 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes. Mattson DH; Shimojo N; Cowan EP; Baskin JJ; Turner RV; Shvetsky BD; Coligan JE; Maloy WL; Biddison WE J Immunol; 1989 Aug; 143(4):1101-7. PubMed ID: 2473117 [TBL] [Abstract][Full Text] [Related]
14. The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2. Bednarek MA; Sauma SY; Gammon MC; Porter G; Tamhankar S; Williamson AR; Zweerink HJ J Immunol; 1991 Dec; 147(12):4047-53. PubMed ID: 1721637 [TBL] [Abstract][Full Text] [Related]
15. Endogenous loading of HLA-A2 molecules with an analog of the influenza virus matrix protein-derived peptide and its inhibition by an exogenous peptide antagonist. Gammon MC; Bednarek MA; Biddison WE; Bondy SS; Hermes JD; Mark GE; Williamson AR; Zweerink HJ J Immunol; 1992 Jan; 148(1):7-12. PubMed ID: 1727876 [TBL] [Abstract][Full Text] [Related]
16. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells. Zweerink HJ; Gammon MC; Utz U; Sauma SY; Harrer T; Hawkins JC; Johnson RP; Sirotina A; Hermes JD; Walker BD J Immunol; 1993 Mar; 150(5):1763-71. PubMed ID: 7679694 [TBL] [Abstract][Full Text] [Related]
17. In vitro human cytotoxic T cell responses against influenza A virus can be induced and selected by synthetic peptides. Martinon F; Gomard E; Hannoun C; Lévy JP Eur J Immunol; 1990 Oct; 20(10):2171-6. PubMed ID: 2242754 [TBL] [Abstract][Full Text] [Related]
18. Cross-recognition of a mouse H-2-peptide complex by human HLA-restricted cytotoxic T cells. Murray RJ; Brooks JM; Rickinson AB; Rowe M Eur J Immunol; 1990 Mar; 20(3):659-64. PubMed ID: 1690661 [TBL] [Abstract][Full Text] [Related]
19. Clonal T lymphocyte recognition of the fine structure of the HLA-A2 molecule. Brenner MB; McLean J; Yang SY; van der Poel JJ; Pious D; Strominger JL J Immunol; 1985 Jul; 135(1):384-90. PubMed ID: 2582041 [TBL] [Abstract][Full Text] [Related]